Dr. Alyson Connor has over 25 years of experience in the design and conduct of early-phase clinical programs, with emphasis on the use of adaptive and umbrella protocols to streamline the transition from first-in-human to proof-of-concept. 

At Quotient Sciences, Alyson has most recently led the global client services team and has significant experience in the areas of project management, research, and clinical pharmacology. Currently, Alyson is responsible for working with our internal and customer teams to identify and implement best practice approaches for the design, contracting, and delivery of early phase programs.

Alyson holds a PhD in Molecular Virology and a Bachelor of Science degree in Microbiology, both from Newcastle University.